A combination of Dihydroartemisinin and Venetoclax enhances antitumor effect in AML via C-MYC/BCL-XL/MCL-1 triple targeting

Fenglin Li(Thomas Jefferson University), Ying Lu(Ningbo University)
Discover Oncology
April 9, 2025
Cited by 2


Related Papers